Suchergebnisse - "Spudich, Serena"

PubPharm (12)

1

An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy

Erschienen: 2014

von Dahl, V. | Gisslen, M. | Hagberg, L. | +5

2

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

Erschienen: 2013

von Peluso, M. | Meyerhoff, D. | Price, R. | +12

3

Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

Erschienen: 2012

von Valcour, V. | Chalermchai, T. | Sailasuta, N. | +11

4

Reply to Seligman

Erschienen: 2011

von Edén, A. | Fuchs, D. | Hagberg, L. | +5

5

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

Erschienen: 2011

von Spudich, S. | Gisslen, M. | Hagberg, L. | +8

6

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

Erschienen: 2011

von Dahl, V. | Lee, E. | Peterson, J. | +6

7

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

Erschienen: 2010

von Edén, A. | Fuchs, D. | Hagberg, L. | +5

8

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

Erschienen: 2008

von Price, R. | Spudich, S.

9

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

Erschienen: 2007

von Edén, A. | Price, R. | Spudich, S. | +3

10

Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic Virological Suppression and Failure

Erschienen: 2006

von Spudich, S. | Lollo, N. | Liegler, T. | +2